Matthias Schwab studied medicine at the University Erlangen-Nuernberg, Germany followed by fellowships in Children's Medicine and Clinical Pharmacology with board certifications for both disciplines.He has held positions at the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (IKP), Stuttgart, Germany and as visiting professor at St Jude Children’s Research Hospital, Memphis, US. Since 2007 he is chair of Clinical Pharmacology at the University Tuebingen and director of the Department of Clinical Pharmacology, University Hospital Tuebingen and IKP in Stuttgart. MS participates in and/or coordinates a number of national/international research networks and is member of several committees (e.g. President of the German Society of Experimental and Clinical Pharmacology and Toxicology, Member of the German National Academy of Sciences Leopoldina, Member of the Academy ofSciences and Literature, Mainz, Germany), received numerous awards, and is Editor of Pharmacogenetics & Genomics and Section Editor of Genome Medicine for Pharmacogenomics & Personalized Medicine. His scientific accomplishments include >250 peer reviewed publications. His scientific interests focus on pharmacogenomics in cancer therapy particularly related to ADME genes under consideration of the application of novel technologies such as Omics platforms. In addition, his special interest lies in the implementation of research findings into clinical practice.